ATS 2018 International Conference - Mobile

Andrew I. Bayliffe

N/A

GlaxoSmithKline

Session(s)

Plasma sTNFR1 and IL-8 as Prognostic Enrichment Factors for Sepsis Trials [Board No. 714]
Monday, May 21 9:15 AM - 11:15 AM